Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2972 (LINC02972)
- Target
- LINC02972
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other (non-protein-coding RNA)
01
Overview
Long intergenic non-protein coding RNA 2972 (LINC02972) is a member of the long intergenic non-coding RNA (lincRNA) family, defined by transcripts longer than 200 nucleotides, produced from intergenic regions without overlap with protein-coding genes[1][3]. LINC02972 does not encode a protein, and its biological role remains uncharacterized. Analogous to other lincRNAs, its potential functions may include regulation of gene expression, modulation of chromatin structure, and interaction with protein complexes in the cell nucleus[3][5]. There is no evidence that LINC02972 is currently a drug target, nor is it established as a biomarker or linked to specific pathologies such as cancer or neurodegeneration in available data[1]. Synonyms include LINC02972 and AC092490.1. If more structured knowledge on its specific functions, disease relevance, or druggability becomes available, additional biomarker, safety, or mechanism entries could be updated. As of now, LINC02972 is classified as a non-coding RNA of uncertain functional and clinical importance.
- Other names
- LINC02972AC092490.1
02
Mechanism of action
None known for LINC02972. As a non-coding RNA, it is not a drug target in current therapies[1].
03
Biological functions
Gene expression regulation (in analogy to other lincRNAs)Chromatin remodelingTranscriptional regulationRNA stabilizationNuclear architecture modulation
04
Disease associations
Other lincRNAs are implicated in cancer, neurological disease, and cardiovascular diseaseNo direct evidence for LINC02972 involvement in specific diseases in available datasets
05
Safety considerations
None specific to LINC02972 reported. For other lincRNAs, targeting raises concerns such as off-target effects and incomplete understanding of broader physiological roles
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2972 (LINC02972).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2972 (LINC02972).